BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22816134)

  • 1. Advances in image-guided intratumoral drug delivery techniques.
    Solorio L; Patel RB; Wu H; Krupka T; Exner AA
    Ther Deliv; 2010 Aug; 1(2):307-22. PubMed ID: 22816134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size matters: gold nanoparticles in targeted cancer drug delivery.
    Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
    Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptides for cancer therapy: a drug-development opportunity and a drug-delivery challenge.
    Bidwell GL
    Ther Deliv; 2012 May; 3(5):609-21. PubMed ID: 22834405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics.
    Sabnis N; Lacko AG
    Ther Deliv; 2012 May; 3(5):599-608. PubMed ID: 22834404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
    Elbayoumi TA
    Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
    Babu A; Templeton AK; Munshi A; Ramesh R
    AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting polymer implants in cancer therapy.
    Exner AA; Saidel GM
    Expert Opin Drug Deliv; 2008 Jul; 5(7):775-88. PubMed ID: 18590462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiological barrier nanovector technology for cancer applications.
    Sakamoto J; Annapragada A; Decuzzi P; Ferrari M
    Expert Opin Drug Deliv; 2007 Jul; 4(4):359-69. PubMed ID: 17683250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer implants for intratumoral drug delivery and cancer therapy.
    Weinberg BD; Blanco E; Gao J
    J Pharm Sci; 2008 May; 97(5):1681-702. PubMed ID: 17847077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic therapeutic delivery using navigable agents.
    Martel S
    Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to drug delivery in interventional oncology.
    Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.
    Wang Y; Wei X; Zhang C; Zhang F; Liang W
    Ther Deliv; 2010 Aug; 1(2):273-87. PubMed ID: 22816133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-coupled liposomes for targeted delivery to tumor.
    Jain SK; Jain A; Gulbake A; Shilpi S; Khare P
    Ther Deliv; 2010 Aug; 1(2):345-57. PubMed ID: 22816137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibodies with nucleosome-restricted specificity for targeted delivery of chemotherapeutic agents.
    Torchilin VP
    Ther Deliv; 2010 Aug; 1(2):257-72. PubMed ID: 22816132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.